ArticleEndocrine2026
Adrenal Rest Tumors and the clinical course of gonadal dysfunction in adult men with Congenital Adrenal Hyperplasia caused by 21-Hydroxylase Deficiency: A single-center experience with long-term follow-up.
Article in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTesticular adrenal rest tumors (TARTs) are among the most important long-term complications in males with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. The aim of this study was to evaluate the prevalence, clinical characteristics, and hormonal profile associated with TARTs in adult men with CAH.
methodsThis retrospective cohort study included 23 adult male patients with CAH due to 21-hydroxylase deficiency. Clinical, biochemical, genetic and radiological data, including treatment and treatment response, were retrospectively collected, and CYP21A2 genotypes were classified into severity groups. Clinical, laboratory and genetic characteristics were compared between patients with and without TARTs.
resultsAmong 23 patients, TARTs were detected in 11 (48%). Patients with TARTs had significantly higher concentrations of ACTH (384 ng/L) and 17-OHP (96 ng/mL) (both p < 0.001). Of the patients with TARTs, 82% had the salt-wasting phenotype, while 18% had the simple-virilizing phenotype. Group Null genotypes were more frequent in patients with TARTs (90% vs. 20%, p = 0.005). Bilateral testicular involvement was observed in 9/11 patients (82%). Median age at diagnosis of CAH was significantly lower in patients with TARTs [0 (0-44) years] than in those without TARTs [7 (0-63) years] (p = 0.021). No consistent pattern was observed between changes in glucocorticoid therapy and TART regression.
conclusionTARTs are a common complication in adult men with CAH and are associated with impaired testicular function. TARTs were more frequent among patients with severe genotypes and/or inadequate disease control. Early and regular testicular ultrasound screening may facilitate timely diagnosis and help preserve fertility potential.
Indexed as
Identifiers
42804041What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.